VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Search Videos by Topic or Participant
Browse by Series:

Case Study: Postoperative Treatment of Prostate Cancer

Panelists: Raoul S. Concepcion, MD, Urology Associates, PC; Leonard G. Gomella, MD, Jefferson Kimmel; Lawrence I. Karsh, MD, Urology Center of Colorado;
Published: Thursday, Aug 01, 2013
For High-Definition, Click
Moderator, Raoul S. Concepcion, MD, presents a case study of a 62 year-old Caucasian patient with a PSA of 6 ng/mL and a strong family history of prostate cancer. Following an evaluation, the patient decided to undergo a 12-core biopsy, which found that 4 of the 12 cores were 40% to 60% positive for Gleason 4+3 disease.

As a result, the patient elected to undergo robotically assisted radical retropubic prostatectomy. According to the final pathology report, Concepcion explains, the Gleason score was 4+3 and the lesion was pathologic stage T3a with a questionable apical surgical margins. Overall, the patient was node negative without evidence of metastatic disease. At 3 months following surgery, the PSA nadir was determined to be 0.2 ng/mL.

Several of the postoperative indicators seem to note the presence of residual disease, particularly the lack of an undetectable PSA level, believes Leonard G. Gomella, MD. As a result, a nomogram should be utilized to gauge the risk of recurrence. If the risk is greater than 50%, adjuvant radiation therapy should be administered.

Slider Left
Slider Right
For High-Definition, Click
Moderator, Raoul S. Concepcion, MD, presents a case study of a 62 year-old Caucasian patient with a PSA of 6 ng/mL and a strong family history of prostate cancer. Following an evaluation, the patient decided to undergo a 12-core biopsy, which found that 4 of the 12 cores were 40% to 60% positive for Gleason 4+3 disease.

As a result, the patient elected to undergo robotically assisted radical retropubic prostatectomy. According to the final pathology report, Concepcion explains, the Gleason score was 4+3 and the lesion was pathologic stage T3a with a questionable apical surgical margins. Overall, the patient was node negative without evidence of metastatic disease. At 3 months following surgery, the PSA nadir was determined to be 0.2 ng/mL.

Several of the postoperative indicators seem to note the presence of residual disease, particularly the lack of an undetectable PSA level, believes Leonard G. Gomella, MD. As a result, a nomogram should be utilized to gauge the risk of recurrence. If the risk is greater than 50%, adjuvant radiation therapy should be administered.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x